Stock Events

Stock Events

Q BioMed 

$0
6
+$0+0% Monday 20:00

Statistics

Day High
0
Day Low
0
52W High
0.03
52W Low
0
Volume
5,700
Avg. Volume
621
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-1,230.28%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
568,000Revenue
-6.99MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QBIO. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap156.77B
Pfizer is a global pharmaceutical company that competes with Q BioMed in the development and commercialization of various therapeutic drugs.
Merck
MRK
Mkt Cap294.39B
Merck & Co., Inc. is a leading pharmaceutical company that competes in the research, development, and marketing of drugs in areas similar to Q BioMed's focus.
Johnson & Johnson
JNJ
Mkt Cap564.35B
Johnson & Johnson is a diversified healthcare giant that competes with Q BioMed through its pharmaceutical segment in developing treatments for various diseases.
Abbvie
ABBV
Mkt Cap368.57B
AbbVie is a biopharmaceutical company that competes with Q BioMed in the development of advanced therapies for complex diseases.
AMGEN
AMGN
Mkt Cap191.53B
Amgen is a biotechnology company that competes with Q BioMed in the discovery, development, and delivery of innovative medical treatments.
Bristol-Myers Squibb
BMY
Mkt Cap122.85B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Q BioMed in the development of prescription medicines across several therapeutic areas.
Gilead Sciences
GILD
Mkt Cap170.84B
Gilead Sciences is a biopharmaceutical company that competes with Q BioMed in the development and commercialization of innovative therapeutics.
Novartis
NVS
Mkt Cap293.34B
Novartis is a global healthcare company that competes with Q BioMed in researching and marketing a wide range of pharmaceutical products.
Roche
RHHBY
Mkt Cap330.22B
Roche Holding AG is a healthcare company that competes with Q BioMed in the development of pharmaceuticals and diagnostics for improving patient outcomes.
Sanofi
SNY
Mkt Cap115.14B
Sanofi is a global biopharmaceutical company that competes with Q BioMed in the development and marketing of therapeutic solutions in various areas of healthcare.

About

Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutics to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.
Show more...
CEO
Mr. Denis D. Corin
Employees
3
Country
United States
ISIN
US74736N1054

Listings

OTCM
US
QBIO

0 Comments

Share your thoughts

FAQ

What is Q BioMed stock price today?▼
The current price of QBIO is $0 USD — it has increased by +0% in the past 24 hours. Watch Q BioMed stock price performance more closely on the chart.
What is Q BioMed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Q BioMed stocks are traded under the ticker QBIO.
When is the next Q BioMed earnings date?▼
Q BioMed is going to release the next earnings report on April 29, 2026.
What is Q BioMed revenue for the last year?▼
Q BioMed revenue for the last year amounts to 568,000 USD.
What is Q BioMed net income for the last year?▼
QBIO net income for the last year is -6.99M USD.
How many employees does Q BioMed have?▼
As of April 20, 2026, the company has 3 employees.
In which sector is Q BioMed located?▼
Q BioMed operates in the Health & Wellness sector.
When did Q BioMed complete a stock split?▼
The last stock split for Q BioMed was on August 07, 2015 with a ratio of 1.5:1.
Where is Q BioMed headquartered?▼
Q BioMed is headquartered in New York, United States.